Afuco™ Anti-Human CCL20 ADCC Therapeutic Antibody (GSK3050002), ADCC Enhanced
Anti-CCL20 ADCC Enhanced Antibody (GSK3050002) is an ADCC enhanced antibody produced by our Afuco™ platform. GSK3050002 (previously known as KANAb071) is an investigational monoclonal antibody that is an antagonist for human CCL20, a chemokine ligand that binds to the CCR6 receptor. The CCL20/CCR6 interaction is implicated in a range of autoimmune diseases.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-092CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CCL20 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |